Enhancing nurse competence in early recognition of cardiotoxicity

2024-9-14

Outcomes after transcatheter aortic valve replacement in cancer survivors with prior chest radiation therapy: an updated systematic review and meta-analysis

2024-9-12

Routine Ankle-Brachial Index (ABI) measurement: a window into atherosclerosis and early left ventricular dysfunction in patients diagnosed with cancer

2024-9-12

Cardiovascular and venous thromboembolism risks in cancer patients treated with immune checkpoint inhibitors compared to non-users- a multi-center retrospective study

2024-9-7

Use of EMPAgliflozin in the prevention of CARDiotoxicity: the EMPACARD – PILOT trial

2024-9-5

Hypothesis paper: GDF15 demonstrated promising potential in Cancer diagnosis and correlated with cardiac biomarkers

2024-9-4

Association of anthropometric variables with therapy-induced cardiotoxicity in women with breast cancer: a pilot study for a randomized clinical trial

2024-9-4

Outcomes of patients with active cancer after transcatheter aortic valve replacement: an updated meta-analysis

2024-9-2

Cancer therapy-related cardiac dysfunction after radiation therapy for breast cancer: results from the BACCARAT cohort study

2024-8-26

Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditis

2024-8-22

Cardiac adverse events after Chimeric Antigen Receptor (CAR) T cell therapies: an updated systematic review and meta-analysis

2024-8-20

Navigating the crossroads: cardiometabolic risks in cancer survivorship – a comprehensive review

2024-8-13

A case report of fludarabine associated ectopic atrial bradycardia and literature review of fludarabine induced bradycardia

2024-8-9

Cardiac sarcoidosis presenting as multiple right intra-atrial masses mimicking cardiac tumor

2024-8-8

Crosslink between atrial fibrillation and cancer: a therapeutic conundrum

2024-8-7

Hallmarks of cancer in patients with heart failure: data from BIOSTAT-CHF

2024-8-5

Effects of home-based exercise with telehealth guidance in lymphoma cancer survivors entering cardio-oncology rehabilitation: rationale and design of the tele@home study

2024-7-30

Regression of cardiac angiosarcoma in a 17-year-old: a percutaneous biopsy effect

2024-7-23

Frequency of and sex differences in cancer treatment-related cardiac dysfunction in trastuzumab-treated patients with salivary gland cancer: a retrospective cohort study

2024-7-17

Anthracycline therapy induces an early decline of cardiac contractility in low-risk patients with breast cancer

2024-7-16

Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk score

2024-7-15

Prognostic significance of troponin in patients with malignancy (NIHR Health Informatics Collaborative TROP-MALIGNANCY study)

2024-7-5

Characterization of systolic and diastolic function, alongside proteomic profiling, in doxorubicin-induced cardiovascular toxicity in mice

2024-6-22

Red ginseng prevents doxorubicin-induced cardiomyopathy by inhibiting cell death via activating the Nrf2 pathway

2024-6-22

Effectiveness of exercise modalities on breast cancer patient outcomes: a systematic review and meta-analysis

2024-6-18

Immune checkpoint inhibitor-induced cardiotoxicity in patients with lung cancer: a systematic review and meta-analysis

2024-6-17

Navigating the crossroads: cardiometabolic risks in cancer survivorship – a comprehensive review

2024-6-15

Reconstitution of peripheral blood T cell receptor β immune repertoire in immune checkpoint inhibitors associated myocarditis

2024-6-11

The relationship between body composition and left ventricular performance in women with breast, lymphoma, or sarcoma cancer

2024-6-6

Cardiotoxicity from bruton tyrosine kinase inhibitors (BTKi)—an analysis of an administrative health claims database

2024-6-1

Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab

2024-5-29

Secondary cardiac lymphoma presenting with cardiac tamponade and cardiac mass: a case report

2024-5-18

Complex decision making in a patient with lung cancer with incidentally found fast-growing atrial mass

2024-5-18

Immune checkpoint inhibitors and pericardial disease: a systematic review

2024-5-17

Formative research to adapt a cardiac rehabilitation program to breast cancer survivors: the heart health after cancer treatment (HEART-ACT) study

2024-5-17

Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time

2024-5-1

Variants in structural cardiac genes in patients with cancer therapy-related cardiac dysfunction after anthracycline chemotherapy: a case control study

2024-4-30

Nonbacterial thrombotic endocarditis of mitral valve associated with a lymphoproliferative malignancy: case report and literature review

2024-4-19

Right ventricle involvement in patients with breast cancer treated with chemotherapy

2024-4-15

Cancer therapy related cardiac dysfunction as a result of Panitumumab

2024-4-11

Real-world data of cardio-oncologic interventions for cardiovascular adverse events with oral oncolytics

2024-4-9

Cardiac markers in left-sided breast cancer patients receiving adjuvant radiotherapy: a prospective study

2024-4-8

A comprehensive pediatric cardio-oncology program: a single institution approach to cardiovascular care for pediatric patients with cancer and childhood cancer survivors

2024-4-6

Long-term cardiac effects of modern treatment for Hodgkin’s lymphoma

2024-4-4

Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study

2024-3-27

Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patients

2024-3-26

Trastuzumab in patients with breast cancer and pre-existing left ventricular systolic dysfunction

2024-3-15

Early reduction in cardiorespiratory fitness and diastolic reserve following radiation therapy for lung cancer

2024-3-12

Late cardiotoxicity related to HER2-targeted cancer therapy

2024-3-8

Two-dimensional speckle tracking echocardiography in chemotherapy-induced cardiotoxicity in females with breast cancer

2024-3-1